# Jasper Therapeutics, Inc.

> Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.

## Record

| Field | Value |
| --- | --- |
| Representation | alpha-profile-markdown-v4 |
| Protocol | Alpha Governance Facts Protocol 0.1 |
| Schema | alpha.governance.entity.public.v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| Governance record representation | alpha-governance-record-v2 |
| Canonical entity | alpha:company:bd5d2fba-f90f-493e-8051-6143b96532bc |
| Entity type | Company |
| Canonical URL | https://registry.alpha.ac/companies/jasper-therapeutics-inc |
| Publication | PUBLISHED |
| Verification | source_reported |
| Verification schema | alpha-verification-states-v1 |
| Ownership | unclaimed |
| Published claims | 23 |
| Claims under review | 1 |
| Evidence records | 7 |
| Conflicts | 0 |
| Conflicts in internal review | 0 |
| Observed | 2026-10-11T04:47:02.627219+00:00 |
| Last reviewed | 2026-10-11T04:47:02.627219+00:00 |

## Identity

- Legal name: Jasper Therapeutics, Inc.
- Display name: Jasper Therapeutics, Inc.

## Alpha Governance Record

| Field | Value |
| --- | --- |
| Governance Record schema | alpha-governance-record-v2 |
| Ontology | alpha-governance-ontology-v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| As of | 2026-10-11T11:47:53.939681+00:00 |
| Completeness | 0.409 |
| Record Quality | 0.837 |
| Directors | 6 |
| Committees | 5 |
| Governance events | 14 |
| Entity class | public_company |

## Section coverage

| Section | State |
| --- | --- |
| identity | PUBLISHED |
| corporate_structure | NOT_REVIEWED |
| board | PUBLISHED |
| committees | PUBLISHED |
| leadership | PUBLISHED |
| ownership | NOT_REVIEWED |
| financials | NOT_REVIEWED |
| capital_structure | PUBLISHED |
| compensation | NOT_REVIEWED |
| governance | NOT_REVIEWED |
| shareholder_governance | NOT_REVIEWED |
| audit | NOT_REVIEWED |
| legal | NOT_REVIEWED |
| risk | NOT_REVIEWED |
| cyber | NOT_REVIEWED |
| ai_governance | NOT_REVIEWED |
| agent_governance | RESTRICTED |
| markets_external | NOT_REVIEWED |
| events | PUBLISHED |
| relationships | PUBLISHED |
| assessments | PUBLISHED |
| evidence | PUBLISHED |

## Board

- Christian W. Nolet: Director. Status: current. Independent: true. Since: 2021-01-01. Committees: Audit (chair); Audit · Chair; Compensation · Chair (member); Compensation (chair). claim_id=alpha:claim:company:bd5d2fba-f90f-493e-8051-6143b96532bc:leadership_role:5
- Judith Shizuru, M.D., Ph.D.: Director. Status: current. Independent: false. Since: 2018-01-01. claim_id=alpha:claim:company:bd5d2fba-f90f-493e-8051-6143b96532bc:leadership_role:6
- Kurt von Emster: Director. Status: current. Independent: true. Since: 2019-01-01. Committees: Audit (member); Audit; Compensation; Nominating and Governance · Chair (member); Compensation (member); Nominating and Governance (chair). claim_id=alpha:claim:company:bd5d2fba-f90f-493e-8051-6143b96532bc:leadership_role:7
- Ronald A. Martell: Director. Status: current. Independent: false. Since: 2022-01-01. claim_id=alpha:claim:company:bd5d2fba-f90f-493e-8051-6143b96532bc:leadership_role:8
- Svetlana Lucas, Ph.D.: Director. Status: current. Independent: true. Since: 2024-01-01. claim_id=alpha:claim:company:bd5d2fba-f90f-493e-8051-6143b96532bc:leadership_role:9
- Tom Wiggans: Director. Status: current. Independent: true. Since: 2023-01-01. claim_id=alpha:claim:company:bd5d2fba-f90f-493e-8051-6143b96532bc:leadership_role:10

## Committees

- Audit (audit). Chair: Christian W. Nolet. Members: Christian W. Nolet (chair, current); Kurt von Emster (member, current). committee_id=alpha:committee:jasper-therapeutics-inc:audit
- Audit · Chair; Compensation · Chair (audit). Chair: NOT_PUBLISHED. Members: Christian W. Nolet (member, current). committee_id=alpha:committee:jasper-therapeutics-inc:audit-chair-compensation-chair
- Audit; Compensation; Nominating and Governance · Chair (audit). Chair: NOT_PUBLISHED. Members: Kurt von Emster (member, current). committee_id=alpha:committee:jasper-therapeutics-inc:audit-compensation-nominating-and-governance-chair
- Compensation (compensation). Chair: Christian W. Nolet. Members: Christian W. Nolet (chair, current); Kurt von Emster (member, current). committee_id=alpha:committee:jasper-therapeutics-inc:compensation
- Nominating and Governance (nominating_governance). Chair: Kurt von Emster. Members: Kurt von Emster (chair, current). committee_id=alpha:committee:jasper-therapeutics-inc:nominating-and-governance

## Executive leadership

- Edwin Tucker, M.D.: Chief Medical Officer. Status: current. claim_id=alpha:claim:company:bd5d2fba-f90f-493e-8051-6143b96532bc:leadership_role:11
- Herb Cross: Chief Financial Officer and Corporate Secretary [CFO]. Status: current. claim_id=alpha:claim:company:bd5d2fba-f90f-493e-8051-6143b96532bc:leadership_role:12
- Jeet Mahal: Chief Operating Officer [COO]. Status: current. claim_id=alpha:claim:company:bd5d2fba-f90f-493e-8051-6143b96532bc:leadership_role:13
- Ronald A. Martell: President, Chief Executive Officer and Director [CEO]. Status: current. claim_id=alpha:claim:company:bd5d2fba-f90f-493e-8051-6143b96532bc:leadership_role:14

## Governance events

- EXECUTIVE_APPOINTED: Edwin Tucker, M.D. executive of Jasper Therapeutics, Inc., effective 2025-05-19. Effective: 2025-05-19. Detected: 2026-10-11T04:47:02.627219+00:00. event_id=alpha:event:transition:1nbfv5eqaj9m8
- CFO_CHANGED: Herb Cross executive of Jasper Therapeutics, Inc., effective 2025-05-19. Effective: 2025-05-19. Detected: 2026-10-11T04:47:02.627219+00:00. event_id=alpha:event:transition:1cfyyqw7ih6fo
- EXECUTIVE_APPOINTED: Jeet Mahal executive of Jasper Therapeutics, Inc., effective 2025-05-19. Effective: 2025-05-19. Detected: 2026-10-11T04:47:02.627219+00:00. event_id=alpha:event:transition:la35971tnhmuz
- CEO_CHANGED: Ronald A. Martell executive of Jasper Therapeutics, Inc., effective 2025-05-19. Effective: 2025-05-19. Detected: 2026-10-11T04:47:02.627219+00:00. event_id=alpha:event:transition:1vdufzo1wmcngs
- DIRECTOR_APPOINTED: Svetlana Lucas, Ph.D. seat on Jasper Therapeutics, Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-11T04:47:02.627219+00:00. event_id=alpha:event:transition:10tp1sb1jnyryz
- DIRECTOR_APPOINTED: Tom Wiggans seat on Jasper Therapeutics, Inc., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-11T04:47:02.627219+00:00. event_id=alpha:event:transition:19kx0e01rr43b0
- DIRECTOR_APPOINTED: Ronald A. Martell seat on Jasper Therapeutics, Inc., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-11T04:47:02.627219+00:00. event_id=alpha:event:transition:568hls16frbyk
- DIRECTOR_APPOINTED: Christian W. Nolet seat on Jasper Therapeutics, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-11T04:47:02.627219+00:00. event_id=alpha:event:transition:pdadje1r5q3oq
- COMMITTEE_CREATED: Audit · Chair; Compensation · Chair committee of Jasper Therapeutics, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-11T04:47:02.627219+00:00. event_id=alpha:event:transition:9cm6uymrm0i
- COMMITTEE_MEMBER_ADDED: Christian W. Nolet member of Audit · Chair; Compensation · Chair, effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-11T04:47:02.627219+00:00. event_id=alpha:event:transition:1j5jxqg1ihyvq4
- DIRECTOR_APPOINTED: Kurt von Emster seat on Jasper Therapeutics, Inc., effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-11T04:47:02.627219+00:00. event_id=alpha:event:transition:1fs5whx7ufrh3
- COMMITTEE_CREATED: Audit; Compensation; Nominating and Governance · Chair committee of Jasper Therapeutics, Inc., effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-11T04:47:02.627219+00:00. event_id=alpha:event:transition:85kk57u9qcyz
- COMMITTEE_MEMBER_ADDED: Kurt von Emster member of Audit; Compensation; Nominating and Governance · Chair, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-11T04:47:02.627219+00:00. event_id=alpha:event:transition:wglukh11b57gj
- DIRECTOR_APPOINTED: Judith Shizuru, M.D., Ph.D. seat on Jasper Therapeutics, Inc., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-11T04:47:02.627219+00:00. event_id=alpha:event:transition:17xvh4nkrh6jn

## Scoped resources

- `alpha://company/jasper-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/jasper-therapeutics-inc?format=record
- `alpha://company/jasper-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/jasper-therapeutics-inc?format=record&section=identity
- `alpha://company/jasper-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/jasper-therapeutics-inc?format=record&section=corporate-structure
- `alpha://company/jasper-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/jasper-therapeutics-inc?format=record&section=board
- `alpha://company/jasper-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/jasper-therapeutics-inc?format=record&section=committees
- `alpha://company/jasper-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/jasper-therapeutics-inc?format=record&section=leadership
- `alpha://company/jasper-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/jasper-therapeutics-inc?format=record&section=ownership
- `alpha://company/jasper-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/jasper-therapeutics-inc?format=record&section=financials
- `alpha://company/jasper-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/jasper-therapeutics-inc?format=record&section=capital-structure
- `alpha://company/jasper-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/jasper-therapeutics-inc?format=record&section=compensation
- `alpha://company/jasper-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/jasper-therapeutics-inc?format=record&section=governance
- `alpha://company/jasper-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/jasper-therapeutics-inc?format=record&section=shareholder-governance
- `alpha://company/jasper-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/jasper-therapeutics-inc?format=record&section=audit
- `alpha://company/jasper-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/jasper-therapeutics-inc?format=record&section=legal
- `alpha://company/jasper-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/jasper-therapeutics-inc?format=record&section=risk
- `alpha://company/jasper-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/jasper-therapeutics-inc?format=record&section=cyber
- `alpha://company/jasper-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/jasper-therapeutics-inc?format=record&section=ai-governance
- `alpha://company/jasper-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/jasper-therapeutics-inc?format=record&section=agents
- `alpha://company/jasper-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/jasper-therapeutics-inc?format=record&section=ecosystem
- `alpha://company/jasper-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/jasper-therapeutics-inc?format=record&section=events
- `alpha://company/jasper-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/jasper-therapeutics-inc?format=record&section=relationships
- `alpha://company/jasper-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/jasper-therapeutics-inc?format=record&section=assessments
- `alpha://company/jasper-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/jasper-therapeutics-inc?format=record&section=evidence

## Role modules

- NOT_ASSERTED

## Attention

- NO_RECORDS_FOUND

## Committee data

- Claim alpha:claim:company:bd5d2fba-f90f-493e-8051-6143b96532bc:committee_appointment:16: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:christian-w-nolet","name":"Christian W. Nolet"},"source_id":"board_seats"}`
- Claim alpha:claim:company:bd5d2fba-f90f-493e-8051-6143b96532bc:committee_appointment:17: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:kurt-von-emster","name":"Kurt von Emster"},"source_id":"board_seats"}`
- Claim alpha:claim:company:bd5d2fba-f90f-493e-8051-6143b96532bc:committee_appointment:19: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:christian-w-nolet","name":"Christian W. Nolet"},"source_id":"board_seats"}`
- Claim alpha:claim:company:bd5d2fba-f90f-493e-8051-6143b96532bc:committee_appointment:20: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:kurt-von-emster","name":"Kurt von Emster"},"source_id":"board_seats"}`
- Claim alpha:claim:company:bd5d2fba-f90f-493e-8051-6143b96532bc:committee_appointment:22: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:kurt-von-emster","name":"Kurt von Emster"},"source_id":"board_seats"}`

## Leadership

- Christian W. Nolet: Director, Audit · Chair; Compensation · Chair. Claim: alpha:claim:company:bd5d2fba-f90f-493e-8051-6143b96532bc:leadership_role:5. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:2c4d692e9474a3ff273c735b9886874a473d480f9ab0f858cebda4e2c3597afa.
- Judith Shizuru, M.D., Ph.D.: Director. Claim: alpha:claim:company:bd5d2fba-f90f-493e-8051-6143b96532bc:leadership_role:6. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:2c4d692e9474a3ff273c735b9886874a473d480f9ab0f858cebda4e2c3597afa.
- Kurt von Emster: Director, Audit; Compensation; Nominating and Governance · Chair. Claim: alpha:claim:company:bd5d2fba-f90f-493e-8051-6143b96532bc:leadership_role:7. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:2c4d692e9474a3ff273c735b9886874a473d480f9ab0f858cebda4e2c3597afa.
- Ronald A. Martell: Director. Claim: alpha:claim:company:bd5d2fba-f90f-493e-8051-6143b96532bc:leadership_role:8. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:2c4d692e9474a3ff273c735b9886874a473d480f9ab0f858cebda4e2c3597afa.
- Svetlana Lucas, Ph.D.: Director. Claim: alpha:claim:company:bd5d2fba-f90f-493e-8051-6143b96532bc:leadership_role:9. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:2c4d692e9474a3ff273c735b9886874a473d480f9ab0f858cebda4e2c3597afa.
- Tom Wiggans: Director. Claim: alpha:claim:company:bd5d2fba-f90f-493e-8051-6143b96532bc:leadership_role:10. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:2c4d692e9474a3ff273c735b9886874a473d480f9ab0f858cebda4e2c3597afa.
- Edwin Tucker, M.D.: Chief Medical Officer. Claim: alpha:claim:company:bd5d2fba-f90f-493e-8051-6143b96532bc:leadership_role:11. Valid from: 2025-05-19. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7cf90b2c75c0b03147ec81b9a22d6f5217e8c15da6ce4ebd434b486675a66ff0.
- Herb Cross: Chief Financial Officer and Corporate Secretary. Claim: alpha:claim:company:bd5d2fba-f90f-493e-8051-6143b96532bc:leadership_role:12. Valid from: 2025-05-19. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:10c84748d9225bd06faa5403eea590a2dc45de7abf1341c079e1aa5b9cc2c27a.
- Jeet Mahal: Chief Operating Officer. Claim: alpha:claim:company:bd5d2fba-f90f-493e-8051-6143b96532bc:leadership_role:13. Valid from: 2025-05-19. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9bcda93dc77c236cb85024f47393114d4916cc306b076108bbde97eb96f85e3d.
- Ronald A. Martell: President, Chief Executive Officer and Director. Claim: alpha:claim:company:bd5d2fba-f90f-493e-8051-6143b96532bc:leadership_role:14. Valid from: 2025-05-19. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:07af3d87ee04002eb62acb712f1530eff1b423cf402feb91376ab1631a30315a.

## Roles

- PUBLISHED

## Governance

- NOT_ASSERTED

## Board committees

- Audit: Chair Christian W. Nolet; Members Christian W. Nolet (Chair); Kurt von Emster. Claim: alpha:claim:company:bd5d2fba-f90f-493e-8051-6143b96532bc:committee_record:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e8ee6f2647c26f1af01c6bfcc64a62428f82048a735b90b9bb9d3c18d8c2e587.
- Compensation: Chair Christian W. Nolet; Members Christian W. Nolet (Chair); Kurt von Emster. Claim: alpha:claim:company:bd5d2fba-f90f-493e-8051-6143b96532bc:committee_record:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e8ee6f2647c26f1af01c6bfcc64a62428f82048a735b90b9bb9d3c18d8c2e587.
- Nominating and Governance: Chair Kurt von Emster; Members Kurt von Emster (Chair). Claim: alpha:claim:company:bd5d2fba-f90f-493e-8051-6143b96532bc:committee_record:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e8ee6f2647c26f1af01c6bfcc64a62428f82048a735b90b9bb9d3c18d8c2e587.

## Financials

- NOT_ASSERTED

## Workforce

- NOT_ASSERTED

## Market and index context

- PUBLISHED

## Legal Name

- Jasper Therapeutics, Inc.. Claim: alpha:claim:company:bd5d2fba-f90f-493e-8051-6143b96532bc:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3e389cbc56afeaacb4fd9e1a7e1a5ef5756b40aa6aae521c010400d50f9beb80.

## Entity Status

- Public listing published. Claim: alpha:claim:company:bd5d2fba-f90f-493e-8051-6143b96532bc:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3e389cbc56afeaacb4fd9e1a7e1a5ef5756b40aa6aae521c010400d50f9beb80.

## Published Fact

- US. Claim: alpha:claim:company:bd5d2fba-f90f-493e-8051-6143b96532bc:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3e389cbc56afeaacb4fd9e1a7e1a5ef5756b40aa6aae521c010400d50f9beb80.

## Committee Appointment

- Christian W. Nolet: chair, Audit. Claim: alpha:claim:company:bd5d2fba-f90f-493e-8051-6143b96532bc:committee_appointment:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e8ee6f2647c26f1af01c6bfcc64a62428f82048a735b90b9bb9d3c18d8c2e587.
- Kurt von Emster: member, Audit. Claim: alpha:claim:company:bd5d2fba-f90f-493e-8051-6143b96532bc:committee_appointment:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e8ee6f2647c26f1af01c6bfcc64a62428f82048a735b90b9bb9d3c18d8c2e587.
- Christian W. Nolet: chair, Compensation. Claim: alpha:claim:company:bd5d2fba-f90f-493e-8051-6143b96532bc:committee_appointment:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e8ee6f2647c26f1af01c6bfcc64a62428f82048a735b90b9bb9d3c18d8c2e587.
- Kurt von Emster: member, Compensation. Claim: alpha:claim:company:bd5d2fba-f90f-493e-8051-6143b96532bc:committee_appointment:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e8ee6f2647c26f1af01c6bfcc64a62428f82048a735b90b9bb9d3c18d8c2e587.
- Kurt von Emster: chair, Nominating and Governance. Claim: alpha:claim:company:bd5d2fba-f90f-493e-8051-6143b96532bc:committee_appointment:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:e8ee6f2647c26f1af01c6bfcc64a62428f82048a735b90b9bb9d3c18d8c2e587.

## Security Listing

- JSPR (NASDAQ). Claim: alpha:claim:company:bd5d2fba-f90f-493e-8051-6143b96532bc:security_listing:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3e389cbc56afeaacb4fd9e1a7e1a5ef5756b40aa6aae521c010400d50f9beb80.
- JSPRW (NASDAQ). Claim: alpha:claim:company:bd5d2fba-f90f-493e-8051-6143b96532bc:security_listing:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3e389cbc56afeaacb4fd9e1a7e1a5ef5756b40aa6aae521c010400d50f9beb80.

## Coverage states

| Field | Value |
| --- | --- |
| Identity | PUBLISHED |
| Business | PUBLISHED |
| Leadership | PUBLISHED |
| Board and committees | PUBLISHED |
| Governance | NOT_ASSERTED |
| Financials | NOT_ASSERTED |
| Workforce | NOT_ASSERTED |
| Ownership | NOT_ASSERTED |
| Ratings | NOT_PUBLISHED |
| Market and index context | PUBLISHED |

## Public sources

- alpha:projection-evidence:3e389cbc56afeaacb4fd9e1a7e1a5ef5756b40aa6aae521c010400d50f9beb80: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/jasper-therapeutics-inc).
- alpha:projection-evidence:document:2c4d692e9474a3ff273c735b9886874a473d480f9ab0f858cebda4e2c3597afa: [Jasper Therapeutics, Inc. DEF 14A 2025-05-19](https://www.sec.gov/Archives/edgar/data/1788028/000121390025045086/ea0241493-01.htm).
- alpha:projection-evidence:document:7cf90b2c75c0b03147ec81b9a22d6f5217e8c15da6ce4ebd434b486675a66ff0: [JSPR DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1788028/000121390025045086/ea0241493-01.htm).
- alpha:projection-evidence:document:10c84748d9225bd06faa5403eea590a2dc45de7abf1341c079e1aa5b9cc2c27a: [JSPR DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1788028/000121390025045086/ea0241493-01.htm).
- alpha:projection-evidence:document:9bcda93dc77c236cb85024f47393114d4916cc306b076108bbde97eb96f85e3d: [JSPR DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1788028/000121390025045086/ea0241493-01.htm).
- alpha:projection-evidence:document:07af3d87ee04002eb62acb712f1530eff1b423cf402feb91376ab1631a30315a: [JSPR DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1788028/000121390025045086/ea0241493-01.htm).
- alpha:projection-evidence:e8ee6f2647c26f1af01c6bfcc64a62428f82048a735b90b9bb9d3c18d8c2e587: [Audit](https://www.sec.gov/Archives/edgar/data/1788028/000121390025045086/ea0241493-01.htm).

## Rights

| Field | Value |
| --- | --- |
| public_retrieval | allowed |
| agent_retrieval | allowed |
| redistribution | not_granted |
| model_training | not_granted |
| commercial_use | not_specified |
| relationship_pathfinding | not_granted |
| direct_contact | not_granted |

## Limitations

- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.

## Alternate representations

- [Canonical profile](https://registry.alpha.ac/companies/jasper-therapeutics-inc)
- [Public Markdown](https://registry.alpha.ac/companies/jasper-therapeutics-inc.md)
- [Public JSON](https://registry.alpha.ac/api/public/companies/jasper-therapeutics-inc?format=record)
- [JSON-LD](https://registry.alpha.ac/api/public/companies/jasper-therapeutics-inc?format=jsonld)
- MCP resource: `alpha://companies/jasper-therapeutics-inc` at https://mcp.alpha.ac/mcp


## Connected governance records

Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage.

## Critical-risk oversight

Snapshot as of 2026-10-11T11:47:53.766427+00:00; recorded 2026-10-11T11:47:53.766427+00:00. Every published assignment for this snapshot is listed.
Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording.
An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.